Monitoring Calcitriol May Help Prevent Chronic Heart Failure Death
By LabMedica International staff writers Posted on 30 Mar 2015 |
In patients with chronic heart failure, the vitamin D metabolite 1,25-dihydroxyvitamin D (1,25(OH)2D), also called calcitriol, and its ratio to parathyroid hormone (PTH 1-84) may help predict cardiovascular death.
Heart failure, with high morbidity and mortality, is increasingly prevalent worldwide, and biomarkers may help doctors predict heart failure and help patients survive and patients with decreased calcitriol and decreased ratio of calcitriol to PTH might benefit from more aggressive supplementation.
Scientists at the Cliniques Universitaires Saint Luc (Brussels, Belgium) investigated 170 chronic heart failure patients. Overall, 36 patients were female, 134 patients were male, and the average age was 67 years. Their overall mean ejection fraction was 23%, and the origin of heart failure was ischemic in 119 patients and dilated cardiomyopathy in 51 patients. The team examined the ability of calcitriol and its ratio with PTH(1-84) to predict cardiovascular death in chronic heart failure, and determined the patients' calcitriol and PTH(1-84) levels at baseline. The 1,25(OH)2D was measured by a fully automated LIAISON XL 1,25 Dihydroxyvitamin D assay (DiaSorin; Saluggia, Italy).
The investigators found that serum calcitriol levels decreased markedly according to heart failure severity, and that decreased ratios of calcitriol to PTH(1-84) were significantly related to heart failure severity. After eight years of follow-up, the calcitriol and the ratio of calcitriol to PTH(1-84) were strongly able to predict the deaths of 106 patients who died from cardiovascular causes. In patients with heart failure, vitamin D deficiency and hyperparathyroidism are common, and evidence is growing for the role of vitamin D and PTH in worsening heart failure.
Damien Gruson, PhD, professor and associated laboratory director in the Department of Laboratory Medicine and lead study author, said, “We were surprised by the strong predictive power of 1,25(OH)2D and its ratio to 1-84 PTH. It is noteworthy that in this study the 1,25(OH)2D was measured by a novel extraction-free, fully automated assay based on an unique murine monoclonal antibody, which recognizes the conformational change induced by the binding of the 1,25(OH)2D to a recombinant fusion protein. Our results can provide physicians with a new tool - the 1,25(OH)2D to PTH ratio - to risk stratify heart failure patients.” The study was presented at the annual meeting of the Endocrine Society, ENDO 2015 held March 5-8, 2015, in San Diego (CA, USA).
Related Links:
Cliniques Universitaires Saint Luc
DiaSorin
Heart failure, with high morbidity and mortality, is increasingly prevalent worldwide, and biomarkers may help doctors predict heart failure and help patients survive and patients with decreased calcitriol and decreased ratio of calcitriol to PTH might benefit from more aggressive supplementation.
Scientists at the Cliniques Universitaires Saint Luc (Brussels, Belgium) investigated 170 chronic heart failure patients. Overall, 36 patients were female, 134 patients were male, and the average age was 67 years. Their overall mean ejection fraction was 23%, and the origin of heart failure was ischemic in 119 patients and dilated cardiomyopathy in 51 patients. The team examined the ability of calcitriol and its ratio with PTH(1-84) to predict cardiovascular death in chronic heart failure, and determined the patients' calcitriol and PTH(1-84) levels at baseline. The 1,25(OH)2D was measured by a fully automated LIAISON XL 1,25 Dihydroxyvitamin D assay (DiaSorin; Saluggia, Italy).
The investigators found that serum calcitriol levels decreased markedly according to heart failure severity, and that decreased ratios of calcitriol to PTH(1-84) were significantly related to heart failure severity. After eight years of follow-up, the calcitriol and the ratio of calcitriol to PTH(1-84) were strongly able to predict the deaths of 106 patients who died from cardiovascular causes. In patients with heart failure, vitamin D deficiency and hyperparathyroidism are common, and evidence is growing for the role of vitamin D and PTH in worsening heart failure.
Damien Gruson, PhD, professor and associated laboratory director in the Department of Laboratory Medicine and lead study author, said, “We were surprised by the strong predictive power of 1,25(OH)2D and its ratio to 1-84 PTH. It is noteworthy that in this study the 1,25(OH)2D was measured by a novel extraction-free, fully automated assay based on an unique murine monoclonal antibody, which recognizes the conformational change induced by the binding of the 1,25(OH)2D to a recombinant fusion protein. Our results can provide physicians with a new tool - the 1,25(OH)2D to PTH ratio - to risk stratify heart failure patients.” The study was presented at the annual meeting of the Endocrine Society, ENDO 2015 held March 5-8, 2015, in San Diego (CA, USA).
Related Links:
Cliniques Universitaires Saint Luc
DiaSorin
Read the full article by registering today, it's FREE!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
- Free digital version edition of LabMedica International sent by email on regular basis
- Free print version of LabMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of LabMedica International in digital format
- Free LabMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest Clinical Chem. News
- 3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
- POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
- Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
- New Blood Testing Method Detects Potent Opioids in Under Three Minutes
- Wireless Hepatitis B Test Kit Completes Screening and Data Collection in One Step
- Pain-Free, Low-Cost, Sensitive, Radiation-Free Device Detects Breast Cancer in Urine
- Spit Test Detects Breast Cancer in Five Seconds
- Electrochemical Sensors with Next-Generation Coating Advances Precision Diagnostics at POC
- First-Of-Its-Kind Handheld Device Accurately Detects Fentanyl in Urine within Seconds
- New Fluorescent Sensor Array Lights up Alzheimer’s-Related Proteins for Earlier Detection
- Automated Mass Spectrometry-Based Clinical Analyzer Could Transform Lab Testing
- Highly Sensitive pH Sensor to Aid Detection of Cancers and Vector-Borne Viruses
- Non-Invasive Sensor Monitors Changes in Saliva Compositions to Rapidly Diagnose Diabetes
- Breakthrough Immunoassays to Aid in Risk Assessment of Preeclampsia
- Urine Test for Monitoring Changes in Kidney Health Markers Can Predict New-Onset Heart Failure
- AACC Releases Comprehensive Diabetes Testing Guidelines